The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of regorafenib and/or immune checkpoint inhibitors as a second-line therapy for advanced hepatocellular carcinoma: A real-world study from a single center.
 
Songtao Liu
No Relationships to Disclose
 
Xueying Huang
No Relationships to Disclose
 
Jingjing Chen
No Relationships to Disclose
 
Qiaoxin Wei
No Relationships to Disclose
 
Mei Liu
No Relationships to Disclose